Raising Awareness and Support for Renaming Polycystic Ovary Syndrome (PCOS)

A global study led by Monash University highlights improved awareness of PCOS's broad health impacts and strong support for renaming the condition to better reflect its multisystem nature, aiming to enhance diagnosis, care, and research.
Polycystic ovary syndrome (PCOS) affects approximately one in eight women worldwide and is often misunderstood or misrepresented, impacting diagnosis, treatment, and research. A recent study led by Monash University highlights significant progress in increasing awareness about the broader health impacts of PCOS, extending beyond its traditional association with ovarian cysts and reproductive health.
This international research involved surveys of over 7,700 patients and healthcare professionals across six continents, conducted in 2015 and 2023, complemented by face-to-face workshops. The findings reveal improved understanding of PCOS’s diverse features, including metabolic, cardiovascular, skin, and psychological implications, partly due to the dissemination of updated clinical guidelines and patient resources such as the ASKPCOS app.
A major focus of the study is the strong support—76% of healthcare providers and 86% of patients—for renaming the condition. The current name, "polycystic ovary syndrome," often misleads by emphasizing ovarian cysts, which are not true cysts but follicles that have stopped developing. This misnomer contributes to misconceptions, delayed diagnoses, and inadequate care. Many stakeholders favor alternative names that reflect the endocrine and metabolic nature of the disorder, such as "endocrine-responsive disorder" or "metabolic reproductive disorder."
Initiatives led by Professor Helena Teede and collaborating organizations aim to establish a new, more accurate name through a multi-step global consensus process involving professional societies and patient advocacy groups. The goal is to enhance awareness, early diagnosis, and treatment, ultimately improving health outcomes and supporting research funding.
Patients like Lorna Berry, who has PCOS, welcome the proposed change, viewing it as a step towards respect, clarity, and better management of the condition. Her experience underscores the need for ongoing education and holistic, lifelong care.
This movement reflects a broader trend towards recognizing PCOS as a complex, multisystem disorder rather than a solely reproductive issue. The international effort emphasizes the importance of culturally sensitive naming and communication strategies to ensure inclusiveness and effectiveness.
For more information, healthcare professionals and patients are encouraged to participate in the ongoing survey to help shape the new name: PCOS new name survey.
source: https://medicalxpress.com/news/2025-05-polycystic-ovary-syndrome-awareness-significantly.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Stable IVF and IUI Pregnancy Success Rates Across Europe Amid Rising Single Embryo Transfers
European reproductive health data shows stable IVF and IUI pregnancy rates in 2022, with increased use of single embryo transfer enhancing safety and outcomes. Learn about recent trends and progress in ART across Europe.
Study Uses AI to Uncover Disparities in Amputation Rates Among Rural and Minoritized Populations
A new study employing AI uncovers the role of implicit bias in disparities of limb amputation rates among rural and minoritized populations with vascular disease, highlighting the need for equitable treatment guidelines.
Innovative Approaches to Providing Healthcare to Homeless Populations via Telehealth
Telehealth is transforming healthcare access for homeless populations, reducing barriers, and improving engagement in mental health and chronic disease management. Explore how innovative strategies are addressing this underserved community's needs.



